Investigations of the effects of ethanol on warfarin binding to human serum albumin

Journal of Biomedical Science

Volumn 7, Issue 2, 2000, Pages 114-121

  Ha, Chung Eun ^a   Petersen, Charles E ^a   Park, David S ^a   Harohalli, Krishna ^a   Bhagavan, Nadhipuram V ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Binding mechanism; Equilibrium dialysis; Ethanol; Fluorescence; Human serum albumin; Protein ligand interaction; Warfarin

Indexed keywords

ALCOHOL; SERUM ALBUMIN; WARFARIN;

ARTICLE; DISSOCIATION CONSTANT; DRUG BINDING; EQUILIBRIUM DIALYSIS; FLUORESCENCE; PHARMACOKINETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0034072052     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02256617     Document Type: Article

References (25)

1. Adams WL. Potential for adverse drug-alcohol interactions among retirement community residents. J Am Geriatr Soc 43:1021-1025;1995.
2. Avdulov NA, Chochina SV, Daragan VA, Schroeder F, Mayo KH, Wood WG. Direct binding of ethanol to bovine serum albumin a fluorescent and 13C NMR multiplet relaxation study. Biochemistry 35:340-347;1996.
3. Avdulov NA, Wood WG, Harris RA. Effects of ethanol on structural parameters of rat brain membranes: Relationship to genetic differences in ethanol sensitivity. Alcohol Clin Exp Res 18:53-59;1994.
4. Chakrabarti SK. Cooperativity of warfarin binding with human serum albumin induced by free acid anion. Biochem Pharmacol 27: 739-743;1978.
5. Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG. Mechanism of action of ethanol: Initial central nervous system actions. Pharmacol Rev 41:489-537;1989.
6. Garten S, Wosilait WD. Comparative study of the binding of coumarin anticoagulants and serum albumins. Biochem Pharmacol 20: 1661-1668;1971.
7. Harder S, Thurman P, Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 30:416-444;1996.
8. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 358:209-215;1992.
9. Jones AW. The drunkest drinking driver in Sweden: Blood alcohol concentration 0.545%, w/v. J Stud Alcohol 60:400-406;1999.
10. Larsen FG, Larsen CG, Jakobsen P, Brodersen R. Interaction of warfarin with human serum albumin. Mol Pharmacol 27:263-270;1984.
11. Li C, Peoples RW, Weight FF. Alcohol action on a neuronal membrane receptor: Evidence for a direct interaction with the receptor protein. Proc Natl Acad Sci USA 91:8200-8204; 1994.
12. Lubas B, Soltysik-Rasek M, Lesniewska I. Proton nuclear magnetic resonance study of the association of monovalent and divalent alcohols with bovine serum albumin. Biochemistry 18:4943-4951;1979.
13. Maclaren R, Wachsman BA, Swift DK, Kuhl DA. Warfarin resistance associated with intravenous lipid administration: Discussion of propofol and review of the literature. Pharmacotherapy 17:1331-1337;1997.
14. Maes V, Engelborghs Y, Hoebeke J, Maras Y, Vercruysse A. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study. Mol Pharmacol 21:100-107;1982.
15. Ogiso T, Iwaki M, Konishi Y. Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats. J Pharmacobiodyn 5:829-840;1982.
16. O'Reilly RA, Kowitz PE. Studies on the coumarin anticoagulant drugs: Interaction of human plasma albumin and warfarin sodium. J Clin Invest 46:829-837;1967.
17. Orr A, Ivanova VS, Bonner WM. 'Water-bug' dialysis technique. Biotechniques 19/2:204; 1995.
18. Pinkerton TC, Koeplinger KA. Determination of warfarin-human serum albumin protein binding parameters by an improved Hummel-Dreyer high-performance liquid chromatographic method using internal surface reversed-phase columns. Anal Chem 62:2114-2122;1990.
19. Sioris LJ, Weibert RT, Pentel PR. Potentiation of warfarin anticoagulation by sulfisoixazole. Arch Intern Med 140:546-547;1980.
20. Slater SJ, Cox KJA, Lombardi JV, Ho C, Kelly MB, Rubin E, Stubbs CD. Inhibition of protein kinase C by alcohols and anaesthetics. Nature 364:82-84;1993.
21. Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11: 824-832;1975.
22. Sudlow G, Birkett DJ, Wade DN. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052-1061;1976.
23. Taira Z, Terada H. Specific and non-specific ligand binding to serum albumin. Biochem Pharmacol 34:1995-2005;1985.
24. Wilting J, van der Giesen F, Janssen LHM, Weiderman MM, Otagiri M. The effect of albumin conformation on the binding of warfarin to human serum albumin. J Biol Chem 255: 3032-3037;1980.
25. Yacobi A, Udall JA, Levy G. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther 19:552-558;1976.